ミトコンドリアDNA枯渇症候群 MDS
WordNet
- the state of being depleted
- the act of decreasing something markedly
- a pattern of symptoms indicative of some disease
- a complex of concurrent things; "every word has a syndrome of meanings"
- the 4th letter of the Roman alphabet (同)d
PrepTutorEJDIC
- 枯渇,消耗
- (疾患の徴候となる一群の)症徴候,症候群 / (事件・社会的状態などのパターンを示す)徴候形態
- deuteriumの化学記号
- deoxyribonucleic acidディオキシリボ核酸
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/05/26 12:45:25」(JST)
[Wiki en表示]
Mitochondrial DNA depletion syndrome (MDS) refers to a group of autosomal recessive disorders which cause the affected tissues to suffer from a significant drop in mitochondrial DNA. Symptoms may manifest as myopathic, hepatopathic, and/or encephalomyopathic.[1] These syndromes affect tissue found in the muscle, liver, or both the muscle and brain, respectively. The condition is typically fatal in infancy and early childhood, though some have survived to their teenage years with the myopathic variant.[2] There is currently no curative treatment for any form of MDSs, though some preliminary treatments have shown a reduction in symptoms.[3]
Causes
The myopathic form of MDS manifests symptoms within the first year of life, and is diagnosed by higher levels of serum creatine kinase, which is atypical in other mitochondrial myopathies.[4] Myopathic MDSs is strongly correlated to a variety of mutations in the gene TK2, seeing a reduction of TK2 activity to less than 32% in MDS patients found with the mutation. Because TK2 plays a key role in the mitochondrial salvage pathways of several deoxyribonucleoside triphosphates (dNTPs), a lowered activity would lead to less cycling of nucleotides. This lack of nucleotide recycling is detrimental since the mitochondria cannot synthesize entirely new deoxynucleotides, and the inner membrane of the mitochondria prevents the negatively charged nucleotides of the cytosol from entering.[5]
The encephalomyopathic form of MDS is commonly characterized by psychomotor retardation, muscle hypotonia, hearing impairment, and generalized seizures. A common mutation in this form of MDSs involves a mutation in the SUCLA2 gene, which codes for the beta-subunit of SCS-A. This enzyme catalyzes the synthesis of succinate and coenzyme A into succinyl-CoA, but is also associated with the complex formed by nucleoside diphosphate kinase (NDPK) in the last step of the dNTP salvage pathway.[6]
The hepatopathic form of MDS involves the onset of symptoms including hypotonia, hypoglycemia, persistent vomiting, and failure to thrive within the first year of life.[7] Mutations in three genes have been linked to hepatopathic MDS: DGUOK, POLG, and MPV17. DGUOK encodes for mitochondrial deoxyguanosine kinase (dGK), which catalyzes the phosphorylation of deoxyribonucleosides into nucleotides.[8] POLG encodes for the catalytic subunit pol γA, which is part of mitochondrial DNA polymerase.[9]
References
- ^ (Elpeleg, Orly. Inherited Mitochondrial DNA Depletion. Pediatric Research (2003) 54, 153–159)
- ^ Tritschler, H.-J. Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology Volume 42, Issue 1, January 1992, Pages 209-217
- ^ Saito, K. Pyruvate therapy for mitochondrial DNA depletion syndrome. Biochimica et Biophysica Acta (BBA) - General Subjects Volume 1820, Issue 5, May 2012, Pages 632–636
- ^ Moraes, C.T. mtDNA depletion with variable tissue expression: A novel genetic abnormality in mitochondrial diseases. American Journal of Human Genetics Volume 48, Issue 3, March 1991, Pages 492-501
- ^ Saada, A. Deoxyribonucleotides and disorders of mitochondrial DNA integrity. DNA and Cell Biology Volume 23, Issue 12, December 2004, Pages 797-806
- ^ Elpeleg, Orly. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. The American Journal of Human Genetics, Volume 76, Issue 6, 2005, Pages 1081–1086
- ^ Mazziotta, M.R.M. Fatal infantile liver failure associated with mitochondrial DNA depletion. The Journal of Pediatrics Volume 121, Issue 6, December 1992, Pages 896–901
- ^ Wang, L. Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes. Molecular Genetics and Metabolism Volume 84, Issue 1, January 2005, Pages 75–82
- ^ Van Goethem, G. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nature Genetics Volume 28, Issue 3, 2001, Pages 211-212
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Polymerase gamma deficiency (POLG): Clinical course in a child with a two stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh's encephalopathy.
- Scalais E, Francois B, Schlesser P, Stevens R, Nuttin C, Martin JJ, Van Coster R, Seneca S, Roels F, Van Goethem G, Löfgren A, De Meirleir L.SourceDivision of Paediatric Neurology, Centre Hospitalier de Luxembourg, Luxembourg.
- European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.Eur J Paediatr Neurol.2012 Sep;16(5):542-8. Epub 2012 Feb 17.
- AIMS: Description of the clinical course in a child compound heterozygous for POLG1 mutations, neuropathology findings and results of dietary treatment based on fasting avoidance and long chain triglycerides (LCT) restriction.RESULTS: At 3(1/2) months of age the patient presented with severe hypogly
- PMID 22342071
- In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion.
- Bulst S, Holinski-Feder E, Payne B, Abicht A, Krause S, Lochmüller H, Chinnery PF, Walter MC, Horvath R.SourceMedical Genetic Center, Munich, Germany; Friedrich-Baur-Institute, Department of Neurology, Ludwig-Maximilians-University of Munich, Germany.
- Molecular genetics and metabolism.Mol Genet Metab.2012 Sep;107(1-2):95-103. doi: 10.1016/j.ymgme.2012.04.022. Epub 2012 May 3.
- Mitochondrial DNA depletion syndromes are a genetically heterogeneous group of often severe diseases, characterized by reduced cellular mitochondrial DNA content. Investigation of potential therapeutic strategies for mitochondrial DNA depletion syndromes will be dependent on good model systems. We h
- PMID 22608879
Japanese Journal
- ミトコンドリア病(ミトコンドリア呼吸鎖異常症)--最も頻度の高い先天代謝異常症 (ミニ特集 先天代謝異常の診断と治療Update)
- Children's toxicology from bench to bed - Liver Injury (4) : Mitochondrial respiratory chain disorder and liver disease in children
- Murayama Kei,Ohtake Akira
- Journal of toxicological sciences 34(Special Issue II), SP237-SP243, 2009-07
- … Objectives: The present study was aimed to ascertain the contributions of mitochondrial respiratory chain (MRC) enzymes to the development of liver failure and to the liver pathophysiology of metabolic liver diseases. … They were diagnosed as mtDNA depletion syndrome. …
- NAID 110007337715
Related Links
- The mtDNA depletion syndrome (MDS) is a clinically heterogeneous group of mitochondrial disorders characterized by a ... Mitochondrial DNA depletion syndrome; mitochondrial deoxythymidine kinase (TK2); mitochondrial deoxyguanosine ...
- The mitochondrial DNA (mtDNA) depletion syndrome (MDS) is a clinically heterogeneous group of mitochondrial disorders characterized by a reduction of the mtDNA copy number in affected tissues without mutations or rearrangements in the ...
★リンクテーブル★
[★]
[★]
- 英
- mitochondrial DNA depletion syndrome MDS
[★]
[★]
- 関
- dearth、deficiency、deficient、deficit、deplete、deprivation、deprive、lack、paucity、scarce、scarcity、starve
[★]
- 英
- deoxyribonucleic acid
- 同
- デオキシリボ核酸
- 関
- リボ核酸 RNA
[★]
- 関
- mitochondria、mitochondrially、mitochondrion
[★]
ミトコンドリアDNA mtDNA